Habitudes de traitement de l'hypertension en 1996: Données du registre québécois FAMUS

Canadian Family Physician

Volumn 44, Issue FEB., 1998, Pages 306-312

  Laplante, Patrice ^a   Niyonsenga, Théophile ^b   Delisle, Elisabeth ^b   Vanasse, Nathalie ^b   Vanasse, Alain ^b   Grant, Andrew M ^b   Xhignesse, Marianne ^b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CANADA; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; FEMALE; GENERAL PRACTICE; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ORGANIZATION; RISK FACTOR; TREATMENT PLANNING;

EID: 0031979559     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. MacDonald S, Joffres MP, Stachenko SJ, Horlick L, Fodor G. Multiple cardiovascular risk factors in Canadian adults. Can Med Assoc J 1992;146(11):48-56.
2. White CC, Tolsma D, Haynes SG, McGee D. Cardiovascular disease. In: Amler R. Closing the gap: the burden of unnecessary illness. New York: Oxford University Press; 1986. p. 42-3.
3. Myer GM, Carruthers SG, Leene FHH, Haynes RB. Recommendations from the Canadian Hypertension Society Consensus Conference on the Treatment of Hypertension. Can Med Assoc J 1989;140:1141-6.
4. Ogilvie RI, Burgess ED, Cusson JR, Feldman RD, Lexter LA, Myers MG. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacological treatment of essential hypertension. Can Med Assoc J 1993;149(5):575-84.
5. Fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-83.
6. Steven ID, Wilson DH, Wakefield MA, Bellby J, Coffey GA, Esterman AJ, et al. South Australian hypertension survey. General practitioner experiences with drug treatment. Med J Aust 1992;156:641-4.
7. Fotherby MD, Harper GD, Potter JF. General practitioner's management of hypertension in elderly patients. BMJ 1992;305:750-2.
8. Ribacke M. Treatment preferences, return visit planning and factors affecting hypertension practice among general practitioners and internal medicine specialists. J Intern Med 1995;237:473-8.
9. Troein M, Arneson T, Rastram L, Pirie PL, Selander S, Leupker RV. Reported treatment of hypertension by family physicians in Sweden and Minnesota: a physician survey of practice habits. J Intern Med 1995;238:215-21.
10. Psaty B, Koepsell TD, Yanez D, Smith NL, Manolio TA, Heckberst SR, et al. Temporal patterns of antihypertensive medication use among older adults, 1989 through 1992. JAMA 1995;273(18):1436-8.
11. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 1995;311(7000):293-5.
12. McAlister FA, Teo KK, Lewanczuck RZ, Wells G, Montague TJ. Contemporary practice patterns in the management of newly diagnosed hypertension. Can Med Assoc J 1997;157:23-30.
13. Quraeshi S. Tendances en matière de prescription d'antihypertenseurs. Hypertension Can 1994:1-2.
14. Vanasse A, Laplante P, Xhignesse M, Delisle E, Grant A, Bernier R. Monothérapie et hypertension non compliquée : données du registre provincial FAMUS. Hypertension Can 1995:3-7.
15. Grant AM, Delisle E, Dubois S, Niyonsenga T, Bernier R. Implementation of a province-wide computerized network in Quebec: the FAMUS project. MD Comput 1995;12:45-9.
16. Grant AM, Lussier Y, Delisle E, Dubois S, Bernier R. The TEAM evaluation approach to Project FAMUS, a pan-Canadian risk register for primary care. Symp Comput Applicat Med Care Proc (SCAMC) 1992;14:734-8.
17. Lamberts H, Wood M. ICPC: International classification of primary care. Oxford: Oxford University Press; 1987.
18. Feldman DS, Hofmann R, Gagnon J, Simpson J. Stat view II: the solution for data analysis and presentation graphics. Berkeley, Calif: Abacus Inc; 1987.
19. SAS Institute Inc. SAS Guide to macroprocessing. Version 6. 2nd ed. Cary, NC: SAS Institute Inc; 1990.
20. Collège des médecins du Québec. Rapport annuel 1993-1994 du Collège des médecins du Québec. Bulletin officiel. 1994;34(4).
21. Santé Québec, Daveluy C, Chénard L, Levasseur M, Émond A. Et votre coeur, ça va? Rapport de l'Enquête québécoise sur la santé cardiovasculaire 1990. Montréal: Ministère de la santé et des services sociaux; 1994.
22. Genest J Jr, Cohen JS. Clustering of cardiovascular risk factors: targeting high risk individuals. Am J Cardiol 1995;76:8A-20A.
23. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985;291:97-104.
24. Fallen EL, Cairns J, Dafoe W, Frasure-Smith N, Genest J, Massel D, et al. Consensus report: revision of 1991 CCS guidelines. Management of the postmyocardial infarction patient. Can J Cardiol 1995;11(6):477-85.
25. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, et al. Single-drug therapy for hypertension in men: a comparison of six antihypertensive drug agents and placebo. N Engl J Med 1993;328:914-21.
26. Neaton JD, Grimm RH, Prinea RJ, Stamler J, Grandits GA, Elmer PJ, et al. Treatment of Mild Hypertension Study. Final results. JAMA 1993;270:713-22.
27. Edelson JT, Winstein MC, Tosteson AN, William L, Lee TH, Goldman L. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA 1990;263:407-13.